Breast cancer continues to be a disease with tremendous public health significance. Primary
prevention of breast cancer is still not available, so efforts to promote early detection …

Little progress has been made over the last 40 years to eliminate the racial/ethnic
differences in incidence, morbidity, avoidable suffering, and mortality from cancer that result …

Importance To our knowledge, there is no consensus regarding differences in treatment and
mortality between non-Hispanic African American and non-Hispanic White women with triple …

Abstract Background The American Cancer Society, the Centers for Disease Control and
Prevention, the National Cancer Institute, and the North American Association of Central …

Recent reports have highlighted the distinct roles and occasional tension between
randomised controlled trials (RCTs) and population-based observational research (Concato …

Despite the benefit of adjuvant hormonal therapy (HT) on mortality among women with
breast cancer (BC), many women are non-adherent with its use. We investigated the effects …

Purpose While studies have found that adjuvant hormonal therapy for hormone-sensitive
breast cancer (BC) dramatically reduces recurrence and mortality, adherence to medications …

Anthracyclines are used in over 50% of childhood cancer treatment protocols, but their
clinical usefulness is limited by anthracycline-induced cardiotoxicity (ACT) manifesting as …

BACKGROUND Breast carcinomas in African–American patients appear to be more
aggressive than in Caucasian patients due to multifactorial differences. METHODS The …

Importance Difference in breast cancer survival by race is a recognized problem among
Medicare beneficiaries. Objective To determine if racial disparity in breast cancer survival is …